A Study to Compare and Evaluate Intrahepatic cccDNA Reduction After Administrating Clevudine or Entecavir in the Chronic HBV Patients

NCT01266005 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

75

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis B

Interventions

DRUG: Clevudine
DRUG: Entecavir

Sponsor

Bukwang Pharmaceutical